dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Stradella, Agostina |
dc.contributor.author | Feliubadaló, Lídia |
dc.contributor.author | Grau Garces, Èlia |
dc.contributor.author | Velasco, Àngela |
dc.contributor.author | Balmaña Gelpí, Judith |
dc.contributor.author | Rofes, Paula |
dc.contributor.author | del Valle, Jesús |
dc.date.accessioned | 2021-04-08T10:53:28Z |
dc.date.available | 2021-04-08T10:53:28Z |
dc.date.issued | 2019-08 |
dc.identifier.citation | Stradella A, del Valle J, Rofes P, Feliubadaló L, Grau Garces E, Velasco A, et al. Does multilocus inherited neoplasia alleles syndrome have severe clinical expression? J Med Genet. 2019 Aug;56(8):521–5. |
dc.identifier.issn | 1468-6244 |
dc.identifier.uri | https://hdl.handle.net/11351/5830 |
dc.description | Síndromes de cáncer; Panel de genes; Prueba genética |
dc.language.iso | eng |
dc.publisher | BMJ Publishing Group |
dc.relation.ispartofseries | Journal of Medical Genetics;56(8) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Gens del càncer |
dc.subject | Càncer - Prognosi |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | Inheritance Patterns |
dc.title | Does multilocus inherited neoplasia alleles syndrome have severe clinical expression? |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1136/jmedgenet-2018-105700 |
dc.subject.decs | neoplasias |
dc.subject.decs | patrones de herencia |
dc.relation.publishversion | https://jmg.bmj.com/content/56/8/521.long |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | Stradella A] Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. Medical Oncology Department, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. [del Valle J, Rofes P, Feliubadaló L] Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. Centro de Investigación Biomédica en RED (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. [Grau Garces È] Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. [Velasco À] Hereditary Cancer Program, Catalan Institute of Oncology, IDIBGI, Girona, Spain. [Balmaña-Gelpi J] Grup Alt Risc i Prevenció del Càncer, Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 30580288 |
dc.identifier.wos | 000478880800004 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F00563 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F01363 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/SAF2015-68016-R |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |